Experienced in IgG4-Related Disease

Dr. William J. Mccune

Rheumatology
University of Michigan Health
Regents Of The University Of Michigan
1500 E Medical Ctr, Suite 0331, 
Ann Arbor, MI 
Accepting New Patients

Experienced in IgG4-Related Disease
University of Michigan Health
Regents Of The University Of Michigan
1500 E Medical Ctr, Suite 0331, 
Ann Arbor, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Mccune is a Rheumatologist in Ann Arbor, Michigan. Dr. Mccune is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Granulomatosis with Polyangiitis, Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Vasculitis, and Splenectomy. Dr. Mccune is currently accepting new patients.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in MI
Hospital Affiliations
University Of Michigan Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
Call: 734-936-5738
Other Locations
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Ctr Dr, Ann Arbor, MI 48109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: August 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

71 Total Publications

Should CAR-T cells be used as monotherapy?
Should CAR-T cells be used as monotherapy?
Journal: Current opinion in rheumatology
Published: March 26, 2025
View All 71 Publications
Similar Doctors
Distinguished in IgG4-Related Disease
Dr. Alireza Meysami
Rheumatology
Distinguished in IgG4-Related Disease
Dr. Alireza Meysami
Rheumatology

Henry Ford Health System

3031 W Grand Blvd, 
Detroit, MI 
 (34.1 miles away)
313-916-2600
Languages Spoken:
English, Farsi
See accepted insurances
Accepting New Patients
Offers Telehealth

Alireza Meysami is a Rheumatologist in Detroit, Michigan. Dr. Meysami is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Rheumatoid Arthritis (RA), IgG4-Related Disease, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, and Light Chain Deposition Disease (LCDD). Dr. Meysami is currently accepting new patients.

Advanced in IgG4-Related Disease
Dr. Joshua P. June
Rheumatology
Advanced in IgG4-Related Disease
Dr. Joshua P. June
Rheumatology

Great Lakes Center Of Rheumatology

4052 Legacy Parkway, 
Lansing, MI 
 (50.4 miles away)
517-272-9700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joshua June is a Rheumatologist in Lansing, Michigan. Dr. June is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Psoriatic Arthritis, Undifferentiated Connective Tissue Disease (UCTD), Psoriasis, and Rheumatoid Arthritis (RA). Dr. June is currently accepting new patients.

Advanced in IgG4-Related Disease
Dr. Ryan J. Massay
Rheumatology
Advanced in IgG4-Related Disease
Dr. Ryan J. Massay
Rheumatology

Regents Of The University Of Michigan

355 Briarwood Cir, 
Ann Arbor, MI 
 (3.0 miles away)
734-998-7710
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ryan Massay is a Rheumatologist in Ann Arbor, Michigan. Dr. Massay is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are VEXAS Syndrome, Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), and Rheumatoid Pneumoconiosis. Dr. Massay is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccune's expertise for a condition
ConditionClose
  • Elite
  • Granulomatosis with Polyangiitis
    Dr. Mccune is
    Elite
    . Learn about Granulomatosis with Polyangiitis.
    See more Granulomatosis with Polyangiitis experts
  • Systemic Lupus Erythematosus (SLE)
    Dr. Mccune is
    Elite
    . Learn about Systemic Lupus Erythematosus (SLE).
    See more Systemic Lupus Erythematosus (SLE) experts
  • Distinguished
  • Lupus Nephritis
    Dr. Mccune is
    Distinguished
    . Learn about Lupus Nephritis.
    See more Lupus Nephritis experts
  • Necrotizing Vasculitis
    Dr. Mccune is
    Distinguished
    . Learn about Necrotizing Vasculitis.
    See more Necrotizing Vasculitis experts
  • Vasculitis
    Dr. Mccune is
    Distinguished
    . Learn about Vasculitis.
    See more Vasculitis experts
  • Advanced
  • Behcet Disease
    Dr. Mccune is
    Advanced
    . Learn about Behcet Disease.
    See more Behcet Disease experts
  • Cryoglobulinemia
    Dr. Mccune is
    Advanced
    . Learn about Cryoglobulinemia.
    See more Cryoglobulinemia experts
  • Cutaneous Lupus Erythematosus (CLE)
    Dr. Mccune is
    Advanced
    . Learn about Cutaneous Lupus Erythematosus (CLE).
    See more Cutaneous Lupus Erythematosus (CLE) experts
  • Dermatomyositis
    Dr. Mccune is
    Advanced
    . Learn about Dermatomyositis.
    See more Dermatomyositis experts
  • Familial Mixed Cryoglobulinemia
    Dr. Mccune is
    Advanced
    . Learn about Familial Mixed Cryoglobulinemia.
    See more Familial Mixed Cryoglobulinemia experts
  • Microscopic Polyangiitis
    Dr. Mccune is
    Advanced
    . Learn about Microscopic Polyangiitis.
    See more Microscopic Polyangiitis experts
View All 14 Advanced Conditions
  • Experienced
  • Adult Still's Disease
    Dr. Mccune is
    Experienced
    . Learn about Adult Still's Disease.
    See more Adult Still's Disease experts
  • Ankylosing Spondylitis
    Dr. Mccune is
    Experienced
    . Learn about Ankylosing Spondylitis.
    See more Ankylosing Spondylitis experts
  • Arthritis
    Dr. Mccune is
    Experienced
    . Learn about Arthritis.
    See more Arthritis experts
  • Axial Spondyloarthritis (AxSpA)
    Dr. Mccune is
    Experienced
    . Learn about Axial Spondyloarthritis (AxSpA).
    See more Axial Spondyloarthritis (AxSpA) experts
  • Bursitis
    Dr. Mccune is
    Experienced
    . Learn about Bursitis.
    See more Bursitis experts
  • Calcium Pyrophosphate Arthritis
    Dr. Mccune is
    Experienced
    . Learn about Calcium Pyrophosphate Arthritis.
    See more Calcium Pyrophosphate Arthritis experts
View All 44 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved